Related Experiment Video
Updated: Jan 28, 2026

Chronic Constriction Injury of the Rat's Infraorbital Nerve IoN-CCI to Study Trigeminal Neuropathic Pain
Published on: September 21, 2015
Foxp3 plasmid-encapsulated PLGA nanoparticles attenuate pain behavior in rats with spinal nerve ligation
Juhee Shin1, Yuhua Yin1, Do Kyung Kim2
1Department of Medical Science, Chungnam National University School of Medicine, Daejeon, Republic of Korea; Department of Anatomy, Brain Research Institute, Chungnam National University School of Medicine, Daejeon, Republic of Korea.
Abstract:
Microglia play a critical role in neuropathic pain. Since upregulated Foxp3 in microglia enhances tissue repair by resolving neuroinflammation in excitotoxin-induced neuronal death, it may attenuate neuropathic pain in a similar manner. Therefore, this study tests whether Foxp3 introduced with poly (D, L-lactic-co-glycolic acid) (PLGA) nanoparticles (Foxp3 NPs) can alleviate neuropathic pain by inhibiting microglia activity. The prepared Foxp3 NPs had an anti-inflammatory effect on lipopolysaccharide-stimulated BV2 cells in vitro, and localized to spinal microglia in vivo. Further, the Foxp3 NPs significantly attenuated pain behavior induced by spinal nerve ligation in rats for 7 days by suppressing microglial activity, followed by the downregulation of pro-nociceptive genes and the upregulation of anti-nociceptive genes in the spinal dorsal horn. Collectively, these data suggest that Foxp3 NPs effectively relieve neuropathic pain in animals by reducing microglia activity and subsequent modulation of neuroinflammation, and may be of therapeutic value in the treatment of neuropathic pain.
Insights
Foxp3 nanoparticles reduce neuropathic pain by calming overactive microglia, offering potential therapeutic benefits for pain management. This approach targets neuroinflammation to alleviate pain symptoms.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Microglia are key players in neuropathic pain.
- Foxp3 expression in microglia aids tissue repair and resolves neuroinflammation.
- Foxp3 may offer a therapeutic strategy for neuropathic pain.
Purpose of the Study:
- To investigate if Foxp3 nanoparticles (Foxp3 NPs) can alleviate neuropathic pain.
- To determine if Foxp3 NPs inhibit microglia activity to reduce pain.
Main Methods:
- Prepared Foxp3 NPs using poly (D,L-lactic-co-glycolic acid).
- Assessed anti-inflammatory effects on lipopolysaccharide-stimulated BV2 cells in vitro.
- Evaluated Foxp3 NPs' localization to spinal microglia and pain behavior in a rat model of neuropathic pain.
Main Results:
- Foxp3 NPs demonstrated anti-inflammatory effects in vitro.
- Foxp3 NPs localized to spinal microglia in vivo.
- Foxp3 NPs significantly attenuated neuropathic pain behavior in rats for 7 days.
- Treatment suppressed microglial activity, downregulated pro-nociceptive genes, and upregulated anti-nociceptive genes in the spinal dorsal horn.
Conclusions:
- Foxp3 NPs effectively relieve neuropathic pain in animal models.
- The mechanism involves reducing microglia activity and modulating neuroinflammation.
- Foxp3 NPs hold therapeutic potential for treating neuropathic pain.
More Related Videos
Related Concept Videos
Spinal Nerves: Plexus II
The Lumbar Plexus
The lumbar plexus is situated within the lumbar region of the back and is primarily formed by the first four lumbar spinal nerves (L1 to L4). This plexus extends its branches into several nerves, including the...
Spinal Nerves: Anatomy
There are 31 bilateral pairs of spinal nerves, each emerging from the spinal cord through the intervertebral foramina—openings between adjacent vertebrae. These nerves are...
Spinal Nerves: Plexus I
The Cervical Plexus
The cervical plexus, formed by the anterior rami of the first four...
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Plasmids
Pain

